299 related articles for article (PubMed ID: 7667785)
1. [The effect of the angiotensin-converting enzyme inhibitor enalapril on the rates of progression of chronic kidney failure in patients with different degrees of functional kidney disorders].
Esaian AM; Kaiukov IG; Titova VA
Ter Arkh; 1995; 67(6):57-9. PubMed ID: 7667785
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin converting enzyme inhibitor and chronic renal failure.
Sitprija V; Lumlertgul D
J Med Assoc Thai; 1993 Jul; 76(7):359-67. PubMed ID: 8089635
[TBL] [Abstract][Full Text] [Related]
3. [Angiotensin I converting enzyme inhibitor enalapril in treatment of progressive chronic nephropathy. An open randomized controlled trial].
Kamper AL; Strandgaard S; Leyssac PP
Ugeskr Laeger; 1993 Aug; 155(31):2406-9. PubMed ID: 8346593
[TBL] [Abstract][Full Text] [Related]
4. [A renoprotective effect of enalapril in chronic transplantation nephropathy].
Tomilina NA; Bagdasarian AR; Stoliarevich ES; Sukhanov AV; Fedorova ND; Il'inskiĭ IM; Tyrin VV; Frolov AV
Ter Arkh; 2004; 76(9):47-53. PubMed ID: 15532377
[TBL] [Abstract][Full Text] [Related]
5. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency.
Giri S; Mahajan SK; Sen R; Sharma A
J Assoc Physicians India; 2002 Oct; 50():1245-9. PubMed ID: 12568207
[TBL] [Abstract][Full Text] [Related]
6. Effect of combined treatment of oral sorbent with protein-restricted diet on change of reciprocal creatinine slope in patients with CRF.
Sanaka T; Fujimoto K; Niwayama J; Nishimura H; Naito T; Higuchi C; Akizawa T; Koide K; Koshikawa S
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S35-7. PubMed ID: 12612949
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and renal effects of enalapril therapy for hypertensive patients with chronic renal insufficiency.
Abraham PA; Opsahl JA; Halstenson CE; Keane WF
Arch Intern Med; 1988 Nov; 148(11):2358-62. PubMed ID: 2847667
[TBL] [Abstract][Full Text] [Related]
8. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
[TBL] [Abstract][Full Text] [Related]
9. [The antiproteinuric action of angiotensin-converting enzyme inhibitors in chronic glomerulonephritis and diabetic nephropathy].
Kutyrina IM; Tareeva IE; Shestakova MV; Gerasimenko OI; Zverev KV; Rogov VA; Sheremet'eva OV
Ter Arkh; 1994; 66(6):19-22. PubMed ID: 7940357
[TBL] [Abstract][Full Text] [Related]
10. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
[TBL] [Abstract][Full Text] [Related]
11. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
Ciechanowicz A
Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
[TBL] [Abstract][Full Text] [Related]
12. [Spirapril - a new long-acting ACE inhibitor: efficacy and safety in patients with arterial hypertension in combination with diabetes mellitus and impaired kidney function].
Iakusevich VV; Mozheĭko ME; Paliutin ShKh; Berezina MIu; Martsevich SIu; Shal'nova SA; Deev AD; Kutishenko NP; Alimova EV; Koniakhina IP; Semenova IuE
Ter Arkh; 2000; 72(10):82-6. PubMed ID: 11220887
[TBL] [Abstract][Full Text] [Related]
13. [The effect of angiotensin-converting enzyme inhibitors on left ventricular hypertrophy in patients with chronic glomerulonephritis and pronounced kidney failure].
Diadyk AI; Bagriĭ AE; Lebed' IA; Iarovaia NF; Shchukina EV; Gaĭdukov VO; Gritsenko PV; Diadyk IA
Ter Arkh; 1997; 69(6):24-7. PubMed ID: 9297267
[TBL] [Abstract][Full Text] [Related]
14. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
[TBL] [Abstract][Full Text] [Related]
15. Risk factors of renal failure progression two years prior to dialysis.
Mazouz H; Kacso I; Ghazali A; El Esper N; Moriniere P; Makdassi R; Hardy P; Westeel PF; Achard JM; Pruna A; Fournier A
Clin Nephrol; 1999 Jun; 51(6):355-66. PubMed ID: 10404696
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure and progression of renal failure in the elderly.
Acone D; Cante D; Cillo F; Giordano G; Giordano C
Kidney Int Suppl; 1996 Jun; 55():S75-7. PubMed ID: 8743516
[TBL] [Abstract][Full Text] [Related]
17. Renal pathology and proteinuria determine progression in untreated mild/moderate chronic renal failure.
Williams PS; Fass G; Bone JM
Q J Med; 1988 Apr; 67(252):343-54. PubMed ID: 3205906
[TBL] [Abstract][Full Text] [Related]
18. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
Pozzi C; Del Vecchio L; Locatelli F
G Ital Nefrol; 2002; 19(5):523-8. PubMed ID: 12439840
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of an oral adsorbent on renal function in chronic renal failure: determinants of its efficacy in diabetic nephropathy.
Sanaka T; Akizawa T; Koide K; Koshikawa S
Ther Apher Dial; 2004 Jun; 8(3):232-40. PubMed ID: 15154877
[TBL] [Abstract][Full Text] [Related]
20. [Use of angiotensin-converting enzyme inhibitors in chronic kidney insufficiency].
Kutyrina IM; Lifshits NL; Rogov VA; Kamyshova ES; Shvetsov MIu; Okonova EB; Androsova SO; Martynov SA; Miroshnichenko NG; Gerasimenko OI
Ter Arkh; 2002; 74(6):34-9. PubMed ID: 12136480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
